Grad Intern - Global Patient Safety (Summer 2027)
Amgen
Summary
During this program, you will work with the Late-Stage Oncology Clinical Science team to support the execution of oncology clinical trials. You will gain hands-on experience in clinical data review, study conduct, and cross-functional collaboration while contributing to activities that support the development of innovative therapies for patients with cancer.
Job description
What You Will Do
During this program, you will work with the Late-Stage Oncology Clinical Science team to support the execution of oncology clinical trials. You will gain hands-on experience in clinical data review, study conduct, and cross-functional collaboration while contributing to activities that support the development of innovative therapies for patients with cancer.
- Support clinical development of oncology compounds and assist with day-to-day execution of clinical trials, focusing on data quality.
- Participate in cross-functional discussions involving clinical, statistics, operations, and data management teams.
- Support clinical trial operations by preparing documents such as literature reviews, slide decks, and tracking study progress.
- Learn about and maintain study data quality by performing data review and identifying clinical findings.
- Conduct background research on oncology disease states, treatments, or trial methodologies to support clinical projects.
- Contribute to scientific communication by assisting in preparation of internal presentations and literature summaries.
- Learn about the clinical scientist role in oncology clinical development through meetings, mentorship, and guided projects.
Program Eligibility Requirements
- Must be available to work a full-time schedule.
- Expected continued enrollment in an accredited college or university following the internship program / co-op.
- Student must be located in the United States for the duration of the internship program.
Basic Qualifications
- 18 years or older
- Graduated with a bachelor's degree from an accredited college or university
- Currently enrolled in an MBA program for an MBA internship OR a Master's program for a Master's internship OR a PharmD program for a PharmD internship OR Ph.D. for a PhD internship from an accredited college or university and completion of the first year of MBA OR Master's OR Pharm D OR Ph.D. program before the internship starts
Preferred Qualifications
- Degree concentration(s): Pharmacy
- Excellent written and verbal communication skills.
- Ability to work independently and collaboratively within cross-functional teams.
- Proficiency in Microsoft Office (Word, PowerPoint, Excel).
- Prior experience in clinical research (coursework, clerkships, projects) and/or clinical pharmacy.
- Familiarity with clinical trial processes or regulatory documentation.
- Strong interest in pursuing a career in the pharmaceutical or biotechnology industry.
Requirements
- Must be available to work a full-time schedule
- Expected continued enrollment in an accredited college or university following the internship program
- Student must be located in the United States for the duration of the internship program
- 18 years or older
- Graduated with a bachelor's degree from an accredited college or university
- Currently enrolled in an MBA, Master's, PharmD, or PhD program and completion of the first year before the internship starts
- Excellent written and verbal communication skills
- Ability to work independently and collaboratively within cross-functional teams
- Proficiency in Microsoft Office (Word, PowerPoint, Excel)
- Prior experience in clinical research and/or clinical pharmacy
- Familiarity with clinical trial processes or regulatory documentation
- Strong interest in pursuing a career in the pharmaceutical or biotechnology industry
Benefits
- Competitive benefits
- Networking events
- Community volunteer projects
- Professional growth opportunities
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.